Iodine-125, nuclear medicine

Radioactive iodine is given by tlie primary health care provider, orally as a single dose The effects of iodides are evident within 24 hours, with maximum effects attained after 10 to 15 days of continuous therapy. If the patient is hospitalized, radiation safety precautions identified by the hospital s department of nuclear medicine are followed. 

The utilization of radioisotopes in the field of nuclear medicine has been promoted for various purposes. Among them, diagnostic applications have had much success during the past two decades. Technetium-99m, thallium-210 and iodine-123, for example, have been used as radioisotopes for imaging studies. 

Labeling of iodinated aromatics with radioactive or has proved to be a valuable approach to measure GFR in nuclear medicine. Prominent among these is sodium iothalamate, which is specifically marketed in the US for GFR measurement by the name Glofil . Studies have shown that the clearance of this marker by the glomeruli is reproducible, simple, reliable and accurate, especially in children and those with advanced renal diseases [234]. This marker can also be administered by subcutaneous infusion to obtain GFR values without the need for urine collection [235]. Since very low doses (nanomolar scale) of radioactive aromatics are administered, monitoring of renal function may be achieved without disruption of normal physiologic functions. Concerns over radioactivity and associated handling costs may prevent the use of these compounds for routine GFR measurements. 

The administration of 131I requires safety measurements to reduce to a minimum the irradiation of medical personnel and to avoid contamination of rooms and relatives of patients. Capsules containing 131I are therefore to be preferred to liquid iodine. At doses above 25 mCi (555 MBq), usually intended only for treatment of patients with thyroid cancer, isolation in a specially constructed room of a service for nuclear medicine is necessary. Waste disposal should also be carefully managed so as to avoid overall contamination (5,6). 

Other accelerator-produced radionuclides are also used in nuclear medicine (Table 19.2). One of the most important radionuclides in this group is This radioisotope of iodine has more favourable properties than it emits only y radiation and its relatively short half-life is more appropriate for medical application. Its production is described in section 12.1. Suitable accelerators for the generation of protons of relatively high energy, and transport facilities, are needed. 

I don t say that they should change from basic research to applied research they still may be carrying on the basic research, but they need to explain to the public the importance of it. So many things are discovered. For example, in the case of my discovery of all these radioactive isotopes — technetium-99m, iodine-131, cobalt-60, and cesium-137, all turned out to have tremendous practical applications in nuclear medicine. There are millions of applications per year now. 

Almost all elements found in nature can now be made radioactive. Radioactive potassium and phosphorus are used as tracers to measure how effectively plants take up fertilizer from soil. Radioactive iodine is applied in nuclear medicine to diagnose and treat thyroid problems. Radiation treatment for cancer therapy uses radioactive cobalt, which is made by irradiating ordinary cobalt with neutrons. 

Gamma (y) Sodium iodide doped with thallium iodide are used pSlal(Tl)] thallium, which is present at 0.1-0.4% of sodium emits 420 nm scintillations. This phosphor is very efficient in absorbing y-radiation because of high atomic number of iodine and high density of sodium iodide. Sodium iodide is hermetically sealed. It is normally used in well counters. A typical well counter used in laboratory and that used in cameras in nuclear medicine are show in Figs. 3 and 4. 

Cobalt-60 was a common isotope for external radiotherapy, but it has mostly been replaced by linear accelerators that provide high-energy electrons (P particles) without a dangerous isotope source. It is still used for food irradiation. Iodine-131 is used to combat diseases of the thyroid and of several types of cancer. A list of isotopes used in nuclear medicine may be found at http //www.cbvcp.com/nmrc/mia.html. 

Sources and Applicators Cesium-13 7, Iridium-192, Radium-226, Phosphorous-32, Stronium-90, Iodine-125 Tens of MBq Therapy and nuclear medicine areas. 

Radiopharma- ceuticals Iodine-131, Iodine-123, Technetium-99m, Thalium-201, Xenon-133 Tens of MBq Storage, nuclear medicine areas and transportation. 

Some persons have thought that the increasing emphasis and development of positron-emitting radiotracers in nuclear medicine would result in a decrease in the development and use of single photon-emitting radiotracers. That this is not the case is illustrated hy the fact that there were 302 presentations involving technetium-99m at the June 2006 annual meeting of the Society of Nuclear Medicine in the United States. Iodine-123 accounted for 88 presentations, and indium-111 for 81. 

Nuclear Medicine iodine-131 is a radioactive isotope that is absorbed by the thyroid gland. It is used in medicine to diagnose and treat diseases of the thyroid. When iodine-131 is administered to a patient, radiation from the isotope creates an image of the gland on film that reveals abnormalities. The image above shows the thyroid of a patient with Graves disease, a treatable disease that is a common cause of an overactive thyroid gland. 

Often the amount of administered radioactivity has been used as the criterion to determine whether a patient should be hospitalized or not. T-treated patients, however, do not have the same iodine kinetics. The clearance of from ablated thyroid cancer patients is much faster than from patients treated for hyperthyroidism. The calculations by Coover et al. (2000) enable the nuclear medicine physician to determine the maximum dose to be prescribed to each individual patient. There is a wide... 

Thyroid carcinoma is the most common endocrine malignancy in the US, with 33550 new cases and 1530 deaths estimated for 2007. For unclear reasons, the annual incidence of thyroid carcinoma has risen over the last two decades (Jemal et ai, 2007). The discovery and use of radioactive iodine are major reasons that nuclear medicine originally achieved its specialty standing and central role in the management of thyroid disease. 

On June 29,1956, studies were begun with the radioactive gas, oxygen-15.1 was a fellow at Hammersmith Hospital in 1957, where 1 learned of the work being carried out and planned for the future. I decided then to have a career in nuclear medicine. My work at Hammersmith Hospital consisted of performing studies of the thyroid in patients with iodine-132, obtained by distillation from tellurium-132. Physicist John Mallard told me to look into the newly developed radionuclide generators being produced by Stang and Richards at Brookhaven National Laboratory after I returned to Hopkins as Chief Medical Resident in June, 1958. 

Iodines are among the most widely u.sed radionuclides, mostly in the medical field. Because of its short half-life and useful beta emission, iodine-131 is used extensively in nuclear medicine. 

One of the major goals of research in nuclear medicine is a drug that can be used to demonstrate the brain blood flow pattern. To do this job, a drug should demonstrate four properties. First, it must carry a radioactive isotope that is a positron emitter (best, a fluorine or an iodine atom, for use with the positron camera) that can be put onto the molecule quickly, synthetically, and which will stay on the molecule, metabolically. Second, as to brain entry, the... 

Goates JJ, Morton KA, Whooten WW, Greenberg HE, Datz EL, Handy JE, Scuderi AJ, Haakenstad AO, and RE Lynch (1990). Comparison of methods for calculating glomerular filtration rate technetium-99m-DTPA scintigraphic analysis, protein-free and whole-plasma clearance of technetium-99m-DTPA and iodine-125-iothalamate clearance. Journal of Nuclear Medicine 31 424-429. 

---